Norgine Germany Switzerland Netherlands United Kingdom France Italy Spain Austria Belgium United States of America
07.08.2025 - 18:06:14X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application for Mavorixafor - licenced to Norgine for commercialisation in Europe.